WHO ICTRP trial
NON-MYELOABLATIVE ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FROM HLA…
EUCTR2004-001035-32-IT · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2004-001035-32-IT |
|---|---|
| Public title | NON-MYELOABLATIVE ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FROM HLA IDENTICAL SIBLING FOR METASTATIC SOFT TISSUE SARCOMAS |
| Scientific title | NON-MYELOABLATIVE ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FROM HLA IDENTICAL SIBLING FOR METASTATIC SOFT TISSUE SARCOMAS |
| Primary sponsor | ITALIAN SARCOMA GROUP |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Italy |
| Conditions | METASTATIC SOFT TISSUE SARCOMAS MedDRA version: 9.1 Level: SOC Classification code 10029104 Term: Neoplasms benign, malignant and unspecified (incl cysts and polyps) |
| Interventions | Product Name: Thiotepa Pharmaceutical Form: Powder for solution for injection INN or Proposed INN: Thiotepa CAS Number: 52-24-4 Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 10- Product Name… |
| Registration date | Mar 14, 2007 |
| Secondary IDs | ISG-STS 04/03 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: